Recently, the list of key core technology research projects in Suzhou for the year 2025 was announced, and Jiangsu Baisaifei Biotechnology Co., Ltd.'s "Research and Development of Biomimetic Anticoagulant Coating Technology for Blood Contact Devices" project was successfully selected.
The selected projects focus on the current situation where the industrialization of anticoagulant coatings for domestic blood contact devices (such as vascular stents, ECMO, etc.) lags behind that of foreign countries. They aim to tackle core challenges such as innovative anticoagulant materials and optimized mass production processes, with the goal of achieving independent controllability of high-end medical coatings and helping domestic devices enhance their international competitiveness.
Baisaifei's selection as a science and technology research project in Suzhou is another key progress after being shortlisted for the national level biomedical material innovation task "unveiling and leading the list". This selection is not only a double affirmation of its technological strength, but also injects key impetus into accelerating the landing of "bottleneck" technology research and the innovation and upgrading of domestic medical devices with the attention and support of local governments.
About Suzhou Science and Technology Research Project
Suzhou City focuses on the "1030" industrial system and future industrial layout of the manufacturing industry, with a focus on key areas such as artificial intelligence, embodied intelligent robots, new energy and new energy vehicles, photonics and new displays, advanced materials, biomedicine and medical equipment, high-end equipment, low altitude economy, new generation information technology, quantum technology, etc. It has launched a science and technology innovation support policy organized by "competition for excellence", "revealing horses and leading", and "horse racing system". This policy aims to promote industrial breakthroughs through three measures: firstly, strengthening cutting-edge technological innovation, supporting universities, research institutes, and enterprises to carry out key core technologies and disruptive original research and development; The second is to promote the transformation of independent innovation achievements, with enterprises as the main body and the market as the guide, accelerating the formation of high-value patents and the landing of major strategic products; The third is to encourage the deep integration of industry, academia and research, support enterprises to hire university experts as resident CTOs, form innovation consortia with the industrial chain, and introduce high-end talent teams such as academicians and chief scientists.
About Baisaifei
Jiangsu Baisaifei Biotechnology Co., Ltd. is a national level "specialized, refined, and innovative" small giant enterprise in the field of surface modification technology for biomaterials. The company has gathered a high-end talent team with an international perspective and interdisciplinary backgrounds in biomaterials, chemical engineering, mechanical automation, and other fields. It has taken the lead in creating a technical service platform covering the entire industry chain of functional coatings in China, providing customers with professional high-end functional coating overall solutions, including coating materials, coated components, coating equipment, and coating testing instrument products. It also offers coating process adaptation services, coating coating commissioning production services, coating inspection and testing services (CMA&CNAS), and coating customization research and development services. Our cooperative clients include hundreds of domestic and foreign enterprises in health-related fields such as neurological intervention, cardiovascular intervention/surgery, urology, digestion, extracorporeal life support, and life science consumables. We have obtained a large number of NMPA, FDA, and CE registration certifications using Baisai Fei coatings.
Since its establishment, Baisaifei has gone through multiple rounds of financing and expansion, with a total financing amount of over 300 million yuan. It has over 22000 square meters of research and development and production sites, including a pilot and production base for 100 ton medical coating materials. With over 200 patent applications, it is the enterprise with the most medical coating related patents in China. Undertook two national level "unveiling and leading" innovation tasks related to anti thrombotic coatings, and accumulated honors and qualifications such as the 25th China Patent Award, national high-tech enterprise, and potential unicorn enterprise in China. Led the first industry standard for the firmness of medical device coatings in China and multiple coating evaluation standards that fill domestic gaps.
